Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype

Endocrinology

Volumn 155, Issue 6, 2014, Pages 2064-2076

  Lee, Seong Min ^a   Bishop, Kathleen A ^a,c   Goellner, Joseph J ^b   O'Brien, Charles A ^b   Pike, J Wesley ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CYCLIC CMP; DIBUTYRYL CYCLIC-3',5'-CYTIDINE MONOPHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; HOMEOSTASIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE; ANALOGS AND DERIVATIVES; ANIMAL; BACTERIAL ARTIFICIAL CHROMOSOME; FEMALE; GENETICS; HUMAN; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYCLIC CMP; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; PHENOTYPE; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84901397833     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1107     Document Type: Article

References (65)

1. Pike JW, Meyer MB. Fundamentals of vitamin D hormone-regulated gene expression. J Steroid Biochem Mol Biol. 2013;pii: S0960-0760(13)00234-3.
2. Pike JW, Meyer MB, Bishop KA. Regulation of target gene expression by the vitamin D receptor -an update on mechanisms. Rev Endocr Metab Disord. 2012;13(1): 45-55.
3. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6): 726-776.
4. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83(6): 841-850.
5. Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev. 2004;25(1): 45-71.
6. Reichrath J, Schilli M, Kerber A, Bahmer FA, Czarnetzki BM, Paus R. Hair follicle expression of 1, 25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol. 1994;131(4): 477-482.
7. Sakai Y, Demay MB. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. Endocrinology. 2000;141(6): 2043-2049.
8. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1, 25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983; 221(4616): 1181-1183.
9. Heine G, Niesner U, Chang HD, et al. 1, 25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol. 2008; 38(8): 2210-2218.
10. Zinser GM, Sundberg JP, Welsh J. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 2002;23(12): 2103-2109.
11. Ellison TI, Smith MK, Gilliam AC, MacDonald PN. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J Invest Dermatol. 2008;128(10): 2508-2517.
12. Quigley DA, To MD, Pérez-Losada J, et al. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature. 2009; 458(7237): 505-508.
13. Mee AP, Hoyland JA, Braidman IP, Freemont AJ, Davies M, Mawer EB. Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections. Bone. 1996;18(4): 295-299.
14. Kogawa M, Anderson PH, Findlay DM, Morris HA, Atkins GJ. The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol. 2010;121(1-2): 277-280.
15. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1, 25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest. 1993;92(3): 1436-1443.
16. Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism. Kidney Int. 2002;62(4): 1196-1207.
17. Halloran BP, DeLuca HF. Appearance of the intestinal cytosolic receptor for 1, 25-dihydroxyvitamin D3 during neonatal development in the rat. J Biol Chem. 1981;256(14): 7338-7342.
18. Baeke F, Korf H, Overbergh L, et al. Human T lymphocytes are direct targets of 1, 25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol. 2010;121(1-2): 221-227.
19. Ordonez-Moran P, Larriba MJ, Pendas-Franco N, Aguilera O, Gonzalez-Sancho JM, Munoz A. Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci. 2005;10: 2723-2749.
20. Dhawan P, Peng X, Sutton AL, et al. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol Cell Biol. 2005;25(1): 472-487.
21. Zella LA, MeyerMB, Nerenz RD, Lee SM, MartowiczML, Pike JW. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol. 2010;24(1): 128-147.
22. Huening M, Yehia G, Molina CA, Christakos S. Evidence for a regulatory role of inducible cAMP early repressor in protein kinase a-mediated enhancement of vitamin D receptor expression and modulation of hormone action. Mol Endocrinol. 2002;16(9): 2052-2064.
23. Qi X, Pramanik R, Wang J, et al. The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition. J Biol Chem. 2002;277(29): 25884-25892.
24. Miyamoto K, Kesterson RA, Yamamoto H, et al. Structural organization of the human vitaminDreceptor chromosomal gene and its promoter. Mol Endocrinol. 1997;11(8): 1165-1179.
25. Pálmer HG, Larriba MJ, García JM, et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med. 2004;10(9): 917-919.
26. de Frutos CA, Dacquin R, Vega S, Jurdic P, Machuca-Gayet I, Nieto MA. Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. EMBO J. 2009;28(6): 686-696.
27. Baker AR, McDonnell DP, Hughes M, et al. Cloning and expression of full-length cDNA encoding human vitaminDreceptor. Proc Natl Acad Sci USA. 1988;85(10): 3294-3298.
28. Kamei Y, Kawada T, Fukuwatari T, Ono T, Kato S, Sugimoto E. Cloning and sequencing of the gene encoding the mouse vitamin D receptor. Gene. 1995;152(2): 281-282.
29. Jehan F, DeLuca HF. Cloning and characterization of the mouse vitamin D receptor promoter. Proc Natl Acad Sci USA. 1997; 94(19): 10138-10143.
30. Zella LA, Kim S, Shevde NK, Pike JW. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1, 25-dihydroxyvitamin D3. Mol Endocrinol. 2006; 20(6): 1231-1247.
31. Li YC, Pirro AE, Amling M, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA. 1997;94(18): 9831-9835.
32. Zella LA, Meyer MB, Nerenz RD, Pike JW. The enhanced hypercalcemic response to 20-epi-1, 25-dihydroxyvitaminD3results from a selective and prolonged induction of intestinal calcium-regulating genes. Endocrinology. 2009;150(8): 3448-3456.
33. Fu Q, Manolagas SC, O'Brien CA. Parathyroid hormone controls receptor activator of NF-βB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol. 2006;26(17): 6453-6468.
34. Yu X, Sabbagh Y, Davis SI, Demay MB, White KE. Genetic dissection of phosphate-and vitamin D-mediated regulation of circulating Fgf23 concentrations. Bone. 2005;36(6): 971-977.
35. Narvaez CJ, Matthews D, Broun E, Chan M, Welsh J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology. 2009;150(2): 651-661.
36. Weber K, Erben RG. Differences in triglyceride and cholesterol metabolism and resistance to obesity in male and female vitamin D receptor knockout mice. J Anim Physiol Anim Nutr (Berl). 2013; 97(4): 675-683.
37. Zinser GM, Welsh J. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis. 2004;25(12): 2361-2372.
38. Ding N, YuRT, Subramaniam N, et al.AvitaminDreceptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153(3): 601-613.
39. Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol. 2007;103(3-5): 521-524.
40. Xue Y, Fleet JC. Intestinal vitaminDreceptor is required for normal calcium and bone metabolism in mice. Gastroenterology. 2009; 136(4): 1317-1327, e1311-1312.
41. Chen CH, Sakai Y, Demay MB. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology. 2001;142(12): 5386-5389.
42. Crofts LA, Hancock MS, Morrison NA, Eisman JA. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci USA. 1998;95(18): 10529-10534.
43. Sunn KL, Cock TA, Crofts LA, Eisman JA, Gardiner EM. Novel N-terminal variant of human VDR. Mol Endocrinol. 2001;15(9): 1599-1609.
44. Silver J, Russell J, Sherwood LM. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA. 1985; 82(12): 4270-4273.
45. Murayama A, Takeyama K, Kitanaka S, et al. Positive and negative regulations of the renal 25-hydroxyvitaminD31a-hydroxylase gene by parathyroid hormone, calcitonin, and 1a, 25(OH)2D3 in intact animals. Endocrinology. 1999;140(5): 2224-2231.
46. Dowd DR, MacDonald PN. The 1, 25-dihydroxyvitamin D3-independent actions of the vitaminDreceptor in skin. J Steroid Biochem Mol Biol. 2010;121(1-2): 317-321.
47. Han S, Chiang JY. Mechanism of vitamin D receptor inhibition of cholesterol 7β-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos. 2009;37(3): 469-478.
48. Gascon-Barré M, Demers C, Mirshahi A, Néron S, Zalzal S, Nanci A. The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology. 2003;37(5): 1034-1042.
49. Boland R, Norman A, Ritz E, Hasselbach W. Presence of a 1, 25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun. 1985;128(1): 305-311.
50. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med. 2008;29(6): 407-414.
51. Harms LR, Burne TH, Eyles DW, McGrath JJ. Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab. 2011;25(4): 657-669.
52. Schmidt DR, Holmstrom SR, Fon Tacer K, Bookout AL, Kliewer SA, Mangelsdorf DJ. Regulation of bile acid synthesis by fat-soluble vitamins A and D. J Biol Chem. 2010;285(19): 14486-14494.
53. Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF. Target cells for 1, 25-dihydroxyvitaminD3in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979;206(4423): 1188-1190.
54. Stumpf WE, Sar M, Clark SA, DeLuca HF. Brain target sites for 1, 25-dihydroxyvitamin D3. Science. 1982;215(4538): 1403-1405.
55. Wang Y, DeLuca HF. Is the vitamin D receptor found in muscle? Endocrinology. 2011;152(2): 354-363.
56. Jurutka PW, Hsieh JC, MacDonald PN, et al. Phosphorylation of serine 208 in the human vitamin D receptor. The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells. J Biol Chem. 1993;268(9): 6791-6799.
57. HilliardGM4th, Cook RG, Weigel NL, Pike JW. 1, 25-dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry. 1994;33(14): 4300-4311.
58. Pike J. Vitamin D3 receptors: structure and function in transcription. Annu Rev Nutr. 1991;11: 189-216.
59. Dowd DR, Sutton AL, Zhang C, MacDonald PN. Comodulators of vitamin D receptor-mediated gene expression. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. Vol 1. 2nd ed. New York, NY: Elsevier/Acadmeic Press;2005: 291-304.
60. Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1, 25-dihydroxyvitamin D-resistant rickets. Endocr Rev. 1999;20(2): 156-188.
61. Ma NS, Malloy PJ, Pitukcheewanont P, Dreimane D, Geffner ME, Feldman D. Hereditary vitamin D resistant rickets: identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy. Bone. 2009;45(4): 743-746.
62. Malloy PJ, Wang J, Srivastava T, Feldman D. Hereditary 1, 25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor. Mol Genet Metab. 2010;99(1): 72-79.
63. Malloy PJ, Tasic V, Taha D, et al. Vitamin D receptor mutations in patients with hereditary 1, 25-dihydroxyvitamin D-resistant rickets. Mol Genet Metab. 2014;111(1): 33-40.
64. Miura D, Manabe K, Ozono K, et al. Antagonistic action of novel 1β, 25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1β, 25-dihydroxyvitamin D3. J Biol Chem. 1999;274(23): 16392-16399.
65. PeräkyläM, Molnár F, Carlberg C.Astructural basis for the speciesspecific antagonism of 26, 23-lactones on vitaminDsignaling.Chem Biol. 2004;11(8): 1147-1156.